SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-18-000225
Filing Date
2018-01-24
Accepted
2018-01-24 17:02:00
Documents
4
Effectiveness Date
2018-01-24

Document Format Files

Seq Description Document Type Size
1 S-8 s-8.htm S-8 115415
2 EX-5.1 ex-5d1.htm EX-5.1 15214
3 EX-23.1 ex-23d1.htm EX-23.1 3844
4 GRAPHIC ex-5d1g001.jpg GRAPHIC 68165
  Complete submission text file 0001558370-18-000225.txt   229456
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-222675 | Film No.: 18545910
SIC: 2834 Pharmaceutical Preparations